β-catenin promotes tumour development by regulating the expression of immune escape-related molecules (CCL4, CD47 and PD-L1) through transcription factors (MYC, TCF/LEF, NF-κβ, SNAI1, etc.)[48, 49]. The gene discussed is NFKB1; the disease is neoplasm.